|
1
|
Knopperts AP, Nielsen M, Niessen RC, Tops
CM, Jorritsma B, Varkevisser J, Wijnen J, Siezen CL, Heine-Bröring
RC, van Kranen HJ, et al: Contribution of biallelic germline MUTYH
mutations to early-onset and familial colorectal cancer and to low
number of adenomatous polyps: Case-series and literature review.
Fam Cancer. 12:43–50. 2013. View Article : Google Scholar
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lovett E: Family studies in cancer of the
colon and rectum. Br J Surg. 63:13–18. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stephenson BM, Finan PJ, Gascoyne J,
Garbett F, Murday VA and Bishop DT: Frequency of familial
colorectal cancer. Br J Surg. 78:1162–1166. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tops CM, Wijnen JT and Hes FJ:
Introduction to molecular and clinical genetics of colorectal
cancer syndromes. Best Pract Res Clin Gastroenterol. 23:127–146.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Järvinen HJ: Hereditary cancer: Guidelines
in clinical practice. Colorectal cancer genetics. Ann Oncol.
15(Suppl 4): iv127–iv131. 2004.PubMed/NCBI
|
|
7
|
Hampel H, Frankel WL, Martin E, Arnold M,
Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman
JA, et al: Feasibility of screening for Lynch syndrome among
patients with colorectal cancer. J Clin Oncol. 26:5783–5788. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Umar A, Boland CR, Terdiman JP, Syngal S,
de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ,
Hamelin R, et al: Revised Bethesda Guidelines for hereditary
nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite
instability. J Natl Cancer Inst. 96:261–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lynch HT and Lynch JF: What the physician
needs to know about Lynch syndrome: an update. Oncology (Williston
Park). 19:455–464. 466–469. 2005.
|
|
10
|
Farrington SM, Tenesa A, Barnetson R,
Wiltshire A, Prendergast J, Porteous M, Campbell H and Dunlop MG:
Germline susceptibility to colorectal cancer due to base-excision
repair gene defects. Am J Hum Genet. 77:112–119. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cleary SP, Cotterchio M, Jenkins MA, Kim
H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N,
et al: Germline MutY human homologue mutations and colorectal
cancer: A multisite case-control study. Gastroenterology.
136:1251–1260. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aaltonen LA, Salovaara R, Kristo P,
Canzian F, Hemminki A, Peltomäki P, Chadwick RB, Kääriäinen H,
Eskelinen M, Järvinen H, et al: Incidence of hereditary
nonpolyposis colorectal cancer and the feasibility of molecular
screening for the disease. N Engl J Med. 338:1481–1487. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ,
Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P,
et al: Localization of the gene for familial adenomatous polyposis
on chromosome 5. Nature. 328:614–616. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schneikert J and Behrens J: The canonical
Wnt signalling pathway and its APC partner in colon cancer
development. Gut. 56:417–425. 2007. View Article : Google Scholar
|
|
15
|
Hanson CA and Miller JR: Non-traditional
roles for the Adenomatous Polyposis Coli (APC) tumor suppressor
protein. Gene. 361:1–12. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nagase H and Nakamura Y: Mutations of the
APC (adenomatous polyposis coli) gene. Hum Mutat. 2:425–434. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miyoshi Y, Nagase H, Ando H, Horii A,
Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T and Nakamura Y:
Somatic mutations of the APC gene in colorectal tumors: Mutation
cluster region in the APC gene. Hum Mol Genet. 1:229–233. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tan ZX, Li FF, Qu YY, Liu J, Liu GR, Zhou
J, Zhu YL and Liu SL: Identification of a known mutation in Notch 3
in familiar CADASIL in China. PLoS One. 7:e365902012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Biasini M, Bienert S, Waterhouse A, Arnold
K, Studer G, Schmidt T, Kiefer F, Cassarino TG, Bertoni M, Bordoli
L, et al: SWISS-MODEL: Modelling protein tertiary and quaternary
structure using evolutionary information. Nucleic Acids Res.
42:W252–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arnold K, Bordoli L, Kopp J and Schwede T:
The SWISS-MODEL workspace: A web-based environment for protein
structure homology modelling. Bioinformatics. 22:195–201. 2006.
View Article : Google Scholar
|
|
21
|
Kiefer F, Arnold K, Künzli M, Bordoli L
and Schwede T: The SWISS-MODEL Repository and associated resources.
Nucleic Acids Res. 37:D387–D392. 2009. View Article : Google Scholar :
|
|
22
|
Guex N, Peitsch MC and Schwede T:
Automated comparative protein structure modeling with SWISS-MODEL
and Swiss-PdbViewer: A historical perspective. Electrophoresis.
30(Suppl 1): S162–S173. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barrow P, Khan M, Lalloo F, Evans DG and
Hill J: Systematic review of the impact of registration and
screening on colorectal cancer incidence and mortality in familial
adenomatous polyposis and Lynch syndrome. Br J Surg. 100:1719–1731.
2013. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Markkanen E, Dorn J and Hübscher U: MUTYH
DNA glycosylase: The rationale for removing undamaged bases from
the DNA. Front Genet. 4:182013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Al-Tassan N, Chmiel NH, Maynard J, Fleming
N, Livingston AL, Williams GT, Hodges AK, Davies DR, David SS,
Sampson JR, et al: Inherited variants of MYH associated with
somatic G:C→T:A mutations in colorectal tumors. Nat Genet.
30:227–232. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jones S, Emmerson P, Maynard J, Best JM,
Jordan S, Williams GT, Sampson JR and Cheadle JP: Biallelic
germline mutations in MYH predispose to multiple colorectal adenoma
and somatic G:C→T:A mutations. Hum Mol Genet. 11:2961–2967. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Filipe B, Baltazar C, Albuquerque C,
Fragoso S, Lage P, Vitoriano I, Mão de Ferro S, Claro I, Rodrigues
P, Fidalgo P, et al: APC or MUTYH mutations account for the
majority of clinically well-characterized families with FAP and
AFAP phenotype and patients with more than 30 adenomas. Clin Genet.
76:242–255. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pezzi A, Roncucci L, Benatti P, Sassatelli
R, Varesco L, Di Gregorio C, Venesio T, Pedroni M, Maffei S,
Reggiani Bonetti L, et al: Relative role of APC and MUTYH mutations
in the pathogenesis of familial adenomatous polyposis. Scand J
Gastroenterol. 44:1092–1100. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ruggieri V, Pin E, Russo MT, Barone F,
Degan P, Sanchez M, Quaia M, Minoprio A, Turco E, Mazzei F, et al:
Loss of MUTYH function in human cells leads to accumulation of
oxidative damage and genetic instability. Oncogene. 32:4500–4508.
2013. View Article : Google Scholar
|
|
30
|
Chmiel NH, Golinelli MP, Francis AW and
David SS: Efficient recognition of substrates and substrate analogs
by the adenine glycosylase MutY requires the C-terminal domain.
Nucleic Acids Res. 29:553–564. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pope MA and David SS: DNA damage
recognition and repair by the murine MutY homologue. DNA Repair
(Amst). 4:91–102. 2005. View Article : Google Scholar
|
|
32
|
Sturt NJ, Gallagher MC, Bassett P, Philp
CR, Neale KF, Tomlinson IP, Silver AR and Phillips RK: Evidence for
genetic predisposition to desmoid tumours in familial adenomatous
polyposis independent of the germline APC mutation. Gut.
53:1832–1836. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schiessling S, Kihm M, Ganschow P, Kadmon
G, Büchler MW and Kadmon M: Desmoid tumour biology in patients with
familial adenomatous polyposis coli. Br J Surg. 100:694–703. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Polakis P: The adenomatous polyposis coli
(APC) tumor suppressor. Biochim Biophys Acta. 1332:F127–F147.
1997.PubMed/NCBI
|
|
35
|
Bertario L, Russo A, Sala P, Eboli M,
Giarola M, D'amico F, Gismondi V, Varesco L, Pierotti MA and Radice
P; Hereditary Colorectal Tumours Registry: Genotype and phenotype
factors as determinants of desmoid tumors in patients with familial
adenomatous polyposis. Int J Cancer. 95:102–107. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ali M, Kim H, Cleary S, Cupples C,
Gallinger S and Bristow R: Characterization of mutant MUTYH
proteins associated with familial colorectal cancer.
Gastroenterology. 135:499–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
U.S. Preventive Services Task Force:
Screening for colorectal cancer: U.S. Preventive Services Task
Force recommendation statement. Ann Intern Med. 149:627–637. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Morrison DS, Batty GD, Kivimaki M, Davey
Smith G, Marmot M and Shipley M: Risk factors for colonic and
rectal cancer mortality: Evidence from 40 years' follow-up in the
Whitehall I study. J Epidemiol Community Health. 65:1053–1058.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Levin B, Smith RA, Feldman GE, Colditz GA,
Fletcher RH, Nadel M, Rothenberger DA, Schroy PS III, Vernon SW and
Wender R; National Colorectal Cancer Roundtable: Promoting early
detection tests for colorectal carcinoma and adenomatous polyps: a
framework for action: the strategic plan of the National Colorectal
Cancer Roundtable. Cancer. 95:1618–1628. 2002. View Article : Google Scholar : PubMed/NCBI
|
